Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT07156253 · RECRUITING

Trial details

NCT number: NCT07156253
Sponsor: Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Solid Tumor Ovarian Cancer Breast Cancer BRCA 1 /2 and / or HRD Advanced Solid Tumors

Start date: 2025-08-26
Primary completion: 2028-08-25
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.